T Cabada1, M Iridoy2, I Jericó2, P Lecumberri3, R Seijas2, A Gargallo1, M Gomez3. 1. Radiology Department, Complejo Hospitalario De Navarra,Spain. 2. Neurology Department, Complejo Hospitalario De Navarra, Spain. 3. Mathematics Department, Universidad Publica De Navarra, Spain.
Abstract
OBJECTIVE: Myotonic dystrophy type 1 (DM1), the most prevalent inherited neuromuscular disease in adults, is a genetic multisystem disorder with a well-established but not well-characterized cerebral involvement. The aim of this study was to evaluate the presence of white matter and gray matter abnormalities in DM1 patients and to investigate their relationship with neurocognitive dysfunction. METHODS: A total of 42 DM1 patients and 42 healthy controls were included in the study. Clinical, cognitive, and magnetic resonance imaging evaluations, including the use of structural and diffusion tensor imaging (DTI) techniques, were performed. White matter lesion (WML) load, volumetric analysis, and diffusivity changes were assessed and correlated with clinical and neuropsychological test findings. RESULTS: WMLs were significantly more frequent in DM1 patients (p < .001), and anterior temporal lobe lesions were only found in the patient group. Global and regional cortical volume loss and corpus callosum atrophy were found. Diffuse white matter DTI abnormalities, including fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity were observed with sparing of the internal capsule. Subcortical structures showed volume loss and increased median diffusivity. Neuropsychological evaluation showed significant impairment in several cognitive functions, but only visuospatial impairment was correlated with white matter abnormalities and cortical atrophy. Daytime sleepiness was associated with WML and ventral diencephalon and pallidum volume loss. CONCLUSION: DM1 produces a widespread involvement of white matter and gray matter, including cortical and subcortical structures. These structural abnormalities are involved in the progressive neuropsychological functional impairment in these patients.
OBJECTIVE: Myotonic dystrophy type 1 (DM1), the most prevalent inherited neuromuscular disease in adults, is a genetic multisystem disorder with a well-established but not well-characterized cerebral involvement. The aim of this study was to evaluate the presence of white matter and gray matter abnormalities in DM1 patients and to investigate their relationship with neurocognitive dysfunction. METHODS: A total of 42 DM1 patients and 42 healthy controls were included in the study. Clinical, cognitive, and magnetic resonance imaging evaluations, including the use of structural and diffusion tensor imaging (DTI) techniques, were performed. White matter lesion (WML) load, volumetric analysis, and diffusivity changes were assessed and correlated with clinical and neuropsychological test findings. RESULTS: WMLs were significantly more frequent in DM1 patients (p < .001), and anterior temporal lobe lesions were only found in the patient group. Global and regional cortical volume loss and corpus callosum atrophy were found. Diffuse white matter DTI abnormalities, including fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity were observed with sparing of the internal capsule. Subcortical structures showed volume loss and increased median diffusivity. Neuropsychological evaluation showed significant impairment in several cognitive functions, but only visuospatial impairment was correlated with white matter abnormalities and cortical atrophy. Daytime sleepiness was associated with WML and ventral diencephalon and pallidum volume loss. CONCLUSION: DM1 produces a widespread involvement of white matter and gray matter, including cortical and subcortical structures. These structural abnormalities are involved in the progressive neuropsychological functional impairment in these patients.
Authors: T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez Journal: Neuroradiology Date: 2020-11-25 Impact factor: 2.804
Authors: Claire Johnson; Kathleen E Langbehn; Jeffrey D Long; David Moser; Stephen Cross; Laurie Gutmann; Peggy C Nopoulos; Ellen van der Plas Journal: J Clin Exp Neuropsychol Date: 2020-10-07 Impact factor: 2.475
Authors: Maud van Dorst; Kees Okkersen; Roy P C Kessels; Frederick J A Meijer; Darren G Monckton; Baziel G M van Engelen; Anil M Tuladhar; Joost Raaphorst Journal: Neuroimage Clin Date: 2018-11-28 Impact factor: 4.881
Authors: Carla Gliem; Martina Minnerop; Sandra Roeske; Hanna Gärtner; Jan-Christoph Schoene-Bake; Sandra Adler; Juri-Alexander Witt; Felix Hoffstaedter; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Katrin Amunts; Thomas Klockgether; Bernd Weber; Cornelia Kornblum Journal: PLoS One Date: 2019-03-07 Impact factor: 3.240
Authors: Sevda Ates; Andreas Deistung; Ruth Schneider; Christian Prehn; Carsten Lukas; Jürgen R Reichenbach; Christiane Schneider-Gold; Barbara Bellenberg Journal: Front Neurol Date: 2019-12-13 Impact factor: 4.003
Authors: Ellen van der Plas; Mark J Hamilton; Jacob N Miller; Timothy R Koscik; Jeffrey D Long; Sarah Cumming; Julija Povilaikaite; Maria Elena Farrugia; John McLean; Ravi Jampana; Vincent A Magnotta; Laurie Gutmann; Darren G Monckton; Peggy C Nopoulos Journal: J Neuromuscul Dis Date: 2019
Authors: Jacob N Miller; Alison Kruger; David J Moser; Laurie Gutmann; Ellen van der Plas; Timothy R Koscik; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos Journal: Front Neurol Date: 2021-07-01 Impact factor: 4.003
Authors: Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola Journal: Front Neurol Date: 2018-09-19 Impact factor: 4.003
Authors: Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia Journal: Front Neurol Date: 2018-10-02 Impact factor: 4.003